NCIC Clinical Trials Group - Canadian Collaborating Clinical Trials Network

Jenna Collier

A novel subpopulation of drug-resistant myeloid-derived suppressor cells may promote the growth of tumour metastases

Breast

Anthony Uren

Cancer Genomics

Non-Hodgkin lymphoma

Shu-Hong Zhu

Nonsmokers and Tobacco Control Norms: Population Surveys and Intervention Studies

Trachea, bronchus and lung

Lisa Rimsza

Molecular Diagnosis and Prognosis in Aggressive Lymphoma

Non-Hodgkin lymphoma

Pathology Hematology and hematologic malignancies

Ann Marie Pendergast

Kinase Target of Diverse Cell Surface Receptors in Cancer Invasion and Metastasis

Breast

Scott H Kaufmann

Anticancer Drug-Induced BH3-only Protein.Bak Interactions

Non-Hodgkin lymphoma

Pathology Hematology and hematologic malignancies

Richard E Champlin

The Therapy of Chronic Myeloid Leukemia (CML)

Leukaemia

Hematology and hematologic malignancies Pathology

Rachael Rigby

Suppressor of cytokine signaling 3 is a key regulator of intestinal epithelial homeostasis

Colorectum

Manuel Caruso

A gene therapy strategy for recessive distrophic epidermolysis bullosa

Leukaemia